Sorry, you need to enable JavaScript to visit this website.

Candidate Through Commercialization

To strengthen our scientific core, we are investing in areas where we see the greatest opportunity and where we believe we can deliver the best value. We also forge novel partnerships that allow us to access the best science.

While we continue to pursue and invest in additional therapies in early and late stages of clinical development, the following are Pfizer's priority focus areas for projects in the candidate through commercialization stages: